Case-based review of assay reproducibility in oncology

About this Webinar

Recent studies suggest that cross-disciplinary review changes the initial assessment in a sizeable minority of cases, a finding echoed by several independent groups. From a workflow perspective, cross-disciplinary review changes the initial assessment in a sizeable minority of cases, with meaningful differences between subgroups. Recent studies suggest that early intervention correlates with better long-term outcomes, with meaningful differences between subgroups. In routine practice, real-world registries complement randomized trial evidence, although confirmatory data are still limited. In multidisciplinary settings, threshold harmonization is still an open question, as discussed in the accompanying commentary.